Spots Global Cancer Trial Database for How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
Official Title: Immunotherapy Multi-omics Specimen Protocol A
Study ID: NCT03370861
Interventions
Study Description
Brief Summary: The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Barnes-Jewish Hosptial, Saint Louis, Missouri, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
